KYTXKyverna Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17886
Ticker: KYTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-02-08
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: KYTX

Detail

Enriched 2026-08-14 20:47

Market cap: $497,839,724.2
Shares outstanding (class): 60,795,212
Shares outstanding (weighted): 61,843,444
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 149
Location: EMERYVILLE, CA
Homepage: https://www.kyvernatx.com
Description: Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Market cap and share counts drift.

Funds holding this security

21 funds · 21 positions · $33.55M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$11.63M	0.00%	1,347,397 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$9.86M	0.09%	1,142,161 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$3.42M	0.00%	396,545 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.17M	0.03%	251,263 NS	FIGI
Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	SURI	$1.49M	2.15%	173,106 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$966.6K	1.13%	112,000 NS	FIGI
WesMark Small Company Fund WesMark Funds	—	$951.9K	0.61%	110,300 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$832.3K	0.07%	96,440 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$696.2K	0.11%	80,673 NS	FIGI
Health Sciences Trust John Hancock Variable Insurance Trust	—	$277.1K	0.12%	32,113 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$250.3K	0.20%	29,000 NS	FIGI
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust	—	$198.2K	0.12%	22,961 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$193.8K	0.00%	22,459 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$146.2K	0.00%	16,941 NS	FIGI
T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC.	—	$143.9K	0.01%	16,677 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERKYTX
FIGI_COMPOSITEBBG00RCYMHR1
FIGI_SHARE_CLASSBBG00RCYMHS0
CIK0001994702
ISINUS5019761049
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.